The first Atara Biotherapeutics trade was made in Q1 2015.
Since then Steven Cohen bought shares eight more times and sold shares on ten occasions. The investor completely sold their stake between Q3 2023 and Q4 2023.
Avg closing price
Price range
Sold -22.2 Thousand shares
Q4 2023
Avg closing price
$23.32
Price range
$5.75
-
$43.50
Sold 3.0% shares (-689 shares)
Q3 2023
Avg closing price
$44.51
Price range
$35.25
-
$57.75
Increased shares by 1999.9% (+21.8 Thousand shares)
Q2 2023
Avg closing price
$56.55
Price range
$37.50
-
$76.00
New holding (+1.09 Thousand shares)
Q1 2023
Avg closing price
$96.99
Price range
$70.00
-
$136.50
Sold -1.2 Thousand shares
Q4 2022
Avg closing price
$104.21
Price range
$71.25
-
$129.50
Sold 99.2% shares (-154 Thousand shares)
Q3 2022
Avg closing price
$110.87
Price range
$3.89
-
$218.25
Sold 5.5% shares (-9.06 Thousand shares)
Q2 2022
Avg closing price
$163.23
Price range
$117.25
-
$246.00
Sold 11.1% shares (-20.4 Thousand shares)
Q1 2022
Avg closing price
$318.44
Price range
$211.00
-
$422.25
Increased shares by 99.0% (+91.8 Thousand shares)
Q4 2021
Avg closing price
$420.98
Price range
$367.50
-
$497.25
Increased shares by 213.3% (+63.1 Thousand shares)
Q3 2021
Avg closing price
$358.27
Price range
$299.75
-
$447.50
Increased shares by 37.8% (+8.11 Thousand shares)
Q2 2021